Clear or Pearly Bump on Skin: Could It Be Cancer?
A pearly, translucent, or skin-coloured bump that you cannot quite explain is one of the classic presentations of basal cell carcinoma (BCC), the most common cancer in humans. It is also a presentation that gets ignored — it does not look like the dark, asymmetric mole most people associate with skin cancer. This guide explains what a pearly bump means, what other harmless conditions can mimic it, and when to act.
What 'pearly' actually means on skin
Pearly describes a specific sheen — translucent, slightly waxy, with a hint of underlying colour rather than a solid pigment. Hold your hand up to a window: a pearly bump has the same quality as a bead of clear glass, where you can almost see beneath the surface. It often catches the light in a way ordinary skin or a pimple does not.
This appearance comes from a tumour of cells that have not produced melanin. Light passes partially through the lesion before reflecting off the deeper layers, creating the characteristic translucent quality. Once you have seen one, you tend to recognise it. Until then, the description does not quite match anything most people have noticed before.
Basal cell carcinoma — the main reason for a pearly bump
Basal cell carcinoma accounts for about 80% of all skin cancers. It almost never spreads to other organs (metastasis is exceptionally rare), but it grows locally and can invade and destroy surrounding tissue if left untreated for years. The classic 'nodular' BCC looks like:
A pearly, translucent papule, typically 2-10mm but can be larger. Usually on the face, ears, scalp, neck, or upper trunk. Often has visible small blood vessels (telangiectasia) on the surface — fine red lines like cracked glass. May have a rolled, slightly raised border around a central depression. The centre may bleed, scab, fall off, and bleed again on a cycle of weeks.
BCC grows slowly. People often have it for months or years before realising. The 'spot that keeps scabbing' on someone's nose or temple is the textbook scenario.
Other clear or pearly things on skin that are NOT cancer
Sebaceous hyperplasia. Small yellowish or pearly bumps with a central depression, common on the forehead and cheeks of adults. Caused by enlarged oil glands. Multiple, stable, benign.
Milia. Tiny white or pearly cysts, usually 1-2mm, often in clusters around the eyes. Trapped keratin. Benign.
Intradermal nevus. A flesh-coloured or pale brown mole that sits deep in the skin. Soft, dome-shaped, stable for years. Benign.
Molluscum contagiosum. Small flesh-coloured papules with a central dimple, viral. More common in children. Resolve over months.
Fibrous papule of the face. A small flesh-coloured firm papule, usually on the nose. Benign.
Syringoma. Small flesh-coloured bumps under the eyes. Sweat-gland origin, benign.
The distinction between these and BCC often requires a dermatoscope. Several of them (sebaceous hyperplasia, fibrous papule of the face) can look strikingly similar to small BCC to the naked eye. This is one of the most common reasons for dermatology referral and biopsy.
Six features that push a pearly bump toward cancer
1. Visible small blood vessels (telangiectasia) on the surface — fine red lines like cracks in glass. Almost pathognomonic for BCC when present.
2. Rolled, raised border around a central depression. The classic 'rodent ulcer' appearance.
3. A central area that bleeds, scabs, and won't heal. The cycle of ulceration distinguishes BCC from benign lesions like sebaceous hyperplasia.
4. Steady growth over months. Sebaceous hyperplasia stays the same size; BCC slowly enlarges.
5. Location on chronically sun-exposed skin in adults — face, ears, scalp, neck, upper back. Less common but still possible on covered areas.
6. The lesion is solitary or new in its area. BCC tends to be a solitary lesion that wasn't there a few years ago. Sebaceous hyperplasia is usually multiple and longstanding.
Less common pearly cancers to know about
Amelanotic melanoma. Can present as a pearly or pink translucent papule. Distinguished from BCC by faster growth, EFG features (Elevated, Firm, Growing), and sometimes a small fleck of pigment somewhere on the lesion. Less common than BCC but more dangerous.
Merkel cell carcinoma. Rare. A firm, fast-growing pink, red, or violet nodule, often on the face, neck, or arms of older adults. Painless. Grows in weeks rather than months.
Sebaceous carcinoma. Rare. A yellow-pink papule or nodule, often on the eyelid or face. Can mimic stye, chalazion, or sebaceous hyperplasia. Important to consider in older adults with a persistent eyelid lesion that does not resolve with normal stye treatment.
Microcystic adnexal carcinoma. Rare. A flesh-coloured indurated plaque, often on the face. Slow-growing but locally aggressive.
When to book a dermatologist
Book within 2-4 weeks for any pearly or translucent bump that is: new in the past year; growing slowly but steadily; bleeding, scabbing, or non-healing; on the face, ears, scalp, or neck of an adult with significant sun exposure history; solitary in an area without similar lesions.
Book within 1-2 weeks for: rapid growth (weeks rather than months); persistent bleeding without injury; lesion in someone with prior history of skin cancer; lesion in an immunosuppressed person.
BCC is highly treatable when caught early. The standard treatment is a small surgical excision under local anaesthetic, often with Mohs surgery for cosmetically sensitive areas like the face. Cure rates exceed 95% for early BCC. The reason to act is not that BCC is dangerous in the short term — it is that delay leads to bigger lesions, larger excisions, and more visible scars.
Spotted a pearly bump? Use our free ABCDE checker for the basics, then book a dermatologist within 4 weeks. For non-pigmented lesions, the EFG rule (Elevated, Firm, Growing) and the 'won't heal in 4 weeks' rule are more useful than ABCDE.
Start free ABCDE checkSources
Content based on clinical guidelines from the American Academy of Dermatology (AAD), British Association of Dermatologists (BAD), and peer-reviewed literature from JAAD, BJD, and JAMA Dermatology. Epidemiological data from NCI SEER and IARC GLOBOCAN. Full methodology